Rammohan Devulapally

Author

Stanford University ORCID

Also Known As

Rammohan Devulapally

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Stanford University University of Pennsylvania Texas A&M University at Qatar

About

Rammohan Devulapally is an author at Stanford University specializing in medicine, radiation oncology, and biomedical engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	5	5	575
2	Medicine	5	5	471
3	Biomedical Engineering	5	5	613
4	Health Sciences	1	1	31
5	Applied Physics	1	1	26

Rammohan Devulapally

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Polymer Nanoparticles Mediated Codelivery of AntimiR-10b and AntimiR-21 for Achieving Triple Negative Breast Cancer Therapy Rammohan Devulapally, Narayana M. Sekar, Thillai V. Sekar, ACS Nano NanomedicineEngineeringPolymer-drug ConjugateMedicineTumor Growth	2015	250
Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer Tzu-Yin Wang, Jung Woo Choe, Kanyi Pu, Journal of Controlled Release NanoparticlesNanomedicineUltrasound-guided DeliveryEngineeringTargeted Drug Delivery	2015	144
Evaluation of integrin αvβ6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis Richard H. Kimura, Ling Wang, Bin Shen, Nature Communications	2019	109
Gemcitabine and Antisense-microRNA Co-encapsulated PLGA–PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy Rammohan Devulapally, Kira Foygel, Thillai V. Sekar, ACS Applied Materials & Interfaces NanoparticlesNanomedicineHcc Cell ViabilityEngineeringHcc Tumors	2016	94
Folate Receptor–Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple-Negative Breast Cancer Ramasamy Paulmurugan, Rohith M. Bhethanabotla, Kaushik Mishra, Molecular Cancer Therapeutics	2015	84
Orlistat and Antisense-miRNA-Loaded PLGA-PEG Nanoparticles for Enhanced Triple Negative Breast Cancer Therapy Aarohi Bhargava-Shah, Kira Foygel, Rammohan Devulapally, Nanomedicine	2016	65
Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivo Jennifer Wischhusen, Sayan Mullick Chowdhury, Taehwa Lee, Journal of Controlled Release Ultrasound-mediated DeliveryHepatologyPathologyMurine Hepatocellular CarcinomaMicrorna Detection	2020	65
Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs Sayan Mullick Chowdhury, Tzu-Yin Wang, Sunitha V. Bachawal, Journal of Controlled Release HepatologyComplementary MicrornasBiomedical EngineeringSmall RnaMicrorna Detection	2016	64
Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells Rammohan Devulapally, Thillai V. Sekar, Ramasamy Paulmurugan Molecular Pharmaceutics Breast OncologyEngineeringPharmacotherapyBiomedical EngineeringTumor Biology	2015	61
Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide <i>in vitro</i> and in a mouse model Meenakshi Malhotra, Thillai Veerapazham Sekar, Jeyarama S. Ananta, Oncotarget	2018	61

Page 1